The pattern of co-mutation of cancer-related genes varied among carcinomas and the groups, with group 1 showing a low frequency of co-mutated genes in all carcinomas and groups 2 and 3 showing varying degrees of mutations in MAPK and PI3K/MTOR pathway genes downstream to ERBB2. This evidence concerns the gene ERBB2 and cancer.